Cancer breakthrough could save children’s lives

Feb 17, 2010

(PhysOrg.com) -- A cancer which claims the lives of thousands of children worldwide every year is a step closer to being cured thanks to a breakthrough by scientists at Newcastle University.

New research, published in the current edition of the American publication Clinical Cancer Research, could offer hope to parents whose suffer relapses after being treated for neuroblastoma.

Neuroblastoma, a cancer mainly affecting children under the age of 5 years, arises from the and can occur anywhere from the neck to the groin but is commonest in the abdomen.

It is the second biggest cancer killer of children in the world and it remains one of the most difficult childhood cancers to cure.

Every year in the UK 100 children will develop the disease and of those about half are in the high risk category.

High risk neuroblastomas have spread to distant sites when discovered in children over a year or 18 months of age, or have unfavourable genetics.

While most neuroblastomas initially respond to treatment, relapsed high risk neuroblastoma is very difficult to cure and in the UK about 30 children die every year from the disease.

But it is hoped the new discovery, which has identified abnormalities in a particular gene called p53, may be one reason why relapses are so hard to cure.

p53 is a tumour suppressor gene which activates cell death or stops cells reproducing after , including that from cancer .

Abnormalities of the pathway were detected in almost 1/2 of the 41 cases of relapsed neuroblastoma that were studied.

Experts hope they will now be able to develop new types of therapies that target the rogue gene which prevents the resurgent cancer being successfully treated.

Dr Deborah Tweddle, Clinical Senior Lecturer at the Northern Institute for Research at Newcastle University and Honorary Consultant Paediatric Oncologist at Newcastle upon Tyne Hospitals NHS Trust, who led the research, said: “Over half of all children who get high risk neuroblastoma will relapse and the chances of surviving a relapse are at present very small.

“This research is one of the first to investigate the cause of relapsed neuroblastoma and finding this link is an important breakthrough in developing new treatments”.

“We are currently developing drugs that reactivate the p53 gene at Newcastle University and elsewhere these types of drugs are now going into clinical trials and may help patients with neuroblastoma”.

“By understanding more about the biology of neuroblastoma at relapse we may be able to prevent it and reduce the deaths of many young children, with its devastating effect on families.

Explore further: Study finds new potential melanoma drug target

Related Stories

Gene that causes childhood cancer neuroblastoma is found

Aug 25, 2008

Scientists have discovered gene mutations that are the main cause of the inherited version of the childhood cancer neuroblastoma. In addition, the researchers found that the same mutations play a significant role in high-risk ...

Immunotherapy effective against neuroblastoma in children

May 14, 2009

A phase III study has shown that adding an antibody-based therapy that harnesses the body's immune system resulted in a 20 percent increase in the number of children living disease-free for at least two years with neuroblastoma. ...

Recommended for you

Study finds new potential melanoma drug target

May 02, 2015

A new treatment for melanoma could be on the horizon, thanks to a finding by a UNC Lineberger Comprehensive Cancer Center-led team. In the study, which was published online today in the journal Clinical Ca ...

Surgery for terminal cancer patients still common

May 02, 2015

The number of surgeries performed on terminally ill cancer patients has not dropped in recent years, despite more attention to the importance of less invasive care for these patients to relieve symptoms and ...

Study provides comprehensive look at brain cancer treatments

May 01, 2015

Led by the Translational Genomics Research Institute (TGen) and UC San Francisco (UCSF), a comprehensive genetic review of treatment strategies for glioblastoma brain tumors was published today in the Oxford University Press ...

How artificial tanning can lead to melanoma

May 01, 2015

Young women may be up on the latest fashions and trends as they prepare for prom season. But what many don't know is that the tan that looks oh-so-good with their dress may be the first step toward skin cancer.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.